There has been concern that Medicare’s “quality” improvement programs–readmission reductions, hospital-acquired conditions elimination, value-based purchasing–have a disproportionate impact on some hospitals, especially those that serve more poor communities and patients. Teaching hospitals are generally affiliated with medical schools and while they often have a reputation for high-quality, they also can score poorly in these programs, and that may be because of the patient populations they treat. A report from an organization representing the colleges, the Association of American Medical Colleges, issues a report indicating the negative revenue impact these programs are having on teaching institutions. (AAMC Report) There are 302 major teaching hospitals; up to 5.5% of their base Medicare revenues are at risk. And for these teaching hospitals, losing revenue is a reality–90% are penalized under the readmissions program, 50% under the acquired-conditions one and 60% under value-based purchasing. Since many of these hospitals have more quality accreditations and perform better on clinical process and outcome measures, there is a serious disjunct somewhere. The researchers divided teaching hospitals into quintiles according to payment adjustments under the programs and looked to see if there were correlations across various factors. The most important correlation was with socio-economic status; hospitals serving more poor patients were more likely to be penalized. This was far and away the most explanatory variable among those examined. The only other one that had even modest explanatory power was teaching intensity–the number of interns per bed. The study once again demonstrates that there are serious flaws in Medicare’s quality programs and that the hospitals which treat more poor people, and need more resources to treat them, are being hurt by the failure to make appropriate adjustments in how performance is calculated.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
September 24, 2023
Relative Spending and Utilization for Medicare Advantage Plans
Medicare Advantage plans have lower utilization and spending than does the Medicare fee-for-service program.
Commentary
September 23, 2023
Stop-loss Insurance Claims for Self-funded Employers
A report on stop-loss insurance reveals increases in number of claims and average cost of…
Commentary
September 22, 2023
Coronamonomania Lives Forever, Part 224
From far across the Pacific comes yet another set of summaries, just like the virus.